PGT-A enables the selection and transfer of healthy embryos by detecting numerical chromosomal abnormalities (aneuploidies) in the embryo. By ruling out aneuploidy conditions related to chromosome number, such as Down and Turner syndromes, it reduces the risk of miscarriage and increases healthy pregnancy rates.
Test Features:
| Feature | Detail |
| Note: Even if PGT-A analysis has been performed, standard ultrasound evaluation and NIPT tests are strongly recommended during pregnancy. | |
| Method | NGS (Next-Generation Sequencing) |
| Coverage | All chromosomes (24 Chromosomes) |
| Sample Requirement | PBS-filled* tube for Day 5 biopsy (trophectoderm) |
| Turnaround Time (TAT) | ~ 10 days |
* Please contact our center for sample submission requirements.
Nesiller Genetic uses PGT-A kits developed by Thermo Fisher Scientific, recognized internationally for their proven clinical reliability. Our laboratory processes are independently assessed each year through GENQA, one of the world’s leading external quality assessment (EQA) programs, ensuring compliance with international quality standards.
19 Mayıs Mah. Çoruh Sok. No:32/1 Fulya, 34394 Şişli / Istanbul, Turkey
Monday - Friday 09:00 - 18:00 Saturday 09:00 - 14:00